Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease.
about
The Role of Emerging Risk Factors in Cardiovascular OutcomesSystematic Review and Meta-Analysis of Drug-Eluting Balloon and Stent for Infrapopliteal Artery Revascularization.Poststroke alterations in heart rate variability during orthostatic challenge.99mTc-labeled bevacizumab for detecting atherosclerotic plaque linked to plaque neovascularization and monitoring antiangiogenic effects of atorvastatin treatment in ApoE-/- miceThe regulatory role of DPP4 in atherosclerotic disease.Atherosclerosis: Successes, Surprises, and Future Challenges.Circulating MiRNA biomarkers serve as a fingerprint for diabetic atherosclerosismiR-155 Regulated Inflammation Response by the SOCS1-STAT3-PDCD4 Axis in Atherogenesis.Perivascular Adipose Tissue Inflammation and Coronary Artery Disease: An Autopsy Study Protocol.Dose-Dependent Induction of an Idiotypic Cascade by Anti-Glycosaminoglycan Monoclonal Antibody in apoE-/- Mice: Association with Atheroprotection.Serum lipid profiles and dyslipidaemia are associated with retinal microvascular changes in children and adolescents.Dietary polyphenols for atherosclerosis: A comprehensive review and future perspectives.Macrophage-derived foam cells impair endothelial barrier function by inducing endothelial-mesenchymal transition via CCL-4.Cysteine proteases in atherosclerosis.Quercetin protects against atherosclerosis by inhibiting dendritic cell activation.Macrophages in Vascular Inflammation: Origins and Functions.Cardiovascular calcification and subcortical bone demineralization in hypertension.A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis.The Roles of TLR Gene Polymorphisms in Atherosclerosis: A Systematic Review and Meta-Analysis of 35,317 Subjects.Erectile dysfunction therapy in countries where implant is economically not feasible.General practitioners' views and preferences about quality improvement feedback in preventive care: a cross-sectional study in Switzerland and France.Overview of preventive practices provided by primary care physicians: A cross-sectional study in Switzerland and France.Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease.MircroRNA-19a promotes vascular inflammation and foam cell formation by targeting HBP-1 in atherogenesisUnderstanding AMD by analogy: systematic review of lipid-related common pathogenic mechanisms in AMD, AD, AS and GN.Association between cardiovascular disease risk scores and subclinical atherosclerosis prevalence in non-elderly adult patients from Argentina.Early Regression of Carotid Intima-Media Thickness after Bariatric Surgery and Its Relation to Serum Leptin Reduction.Polyphenols and Oxidative Stress in Atherosclerosis-Related Ischemic Heart Disease and Stroke.Atherosclerosis & ischaemic heart disease: Here to stay or gone tomorrow.Inhibiting Integrin α5 Cytoplasmic Domain Signaling Reduces Atherosclerosis and Promotes Arteriogenesis.Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.Association between coronary artery disease severity and overactive bladder in geriatric patients.Coronary artery calcium before and after hospitalization with pneumonia: The MESA study.Association of prehypertension and hyperhomocysteinemia with subclinical atherosclerosis in asymptomatic Chinese: a cross-sectional study.Subclinical atherosclerosis, cardiovascular health, and disease risk: is there a case for the Cardiovascular Health Index in the primary prevention population?The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin.Carotid versus coronary atherosclerosis burdens in acute compared with chronic symptomatic coronary artery disease.Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines.Systemic and specific effects of antihypertensive and lipid-lowering medication on plasma protein biomarkers for cardiovascular diseases.Pitfalls in the ankle-brachial index and brachial-ankle pulse wave velocity.
P2860
Q30234550-A9CD1191-6F1E-42B9-90BE-0DA74E765833Q30238932-87993229-BAFC-4D51-A805-E0B6EB80D742Q33168506-4E97E83B-1598-45CB-B535-DBB077B681C3Q33799297-A6CE9FD6-BA84-46E9-8E76-FA0D74F969A9Q33805518-4C5C94D2-21BD-4817-A0C7-0C1CB59EB33DQ36602802-AAD69B69-FFD3-410A-9F03-843696DA3E3BQ37060780-C73B8D7A-8629-4BFD-A948-6B59F93812F2Q37397092-1B6D72AF-30CB-4F24-A195-76D2B32A3F99Q37470199-6347D5FC-86AC-4EF5-B599-02D2EFF64D63Q37677964-427A3B5B-C466-4CCC-AEBD-268B87390D4FQ37710913-5AAB7D71-77E6-4F9D-81A2-C4E1EFEA552BQ38622581-34357003-F80E-45E6-895A-C3E5CA0BC2DAQ38705951-BE401FF7-4B39-4431-A218-8429788B17FAQ38756684-E8D2A873-539F-4E70-BF0F-1FFF3BA33D43Q38812509-334A2EC4-05D7-4CEB-B289-849A8C777664Q38820074-142C847F-7680-46DA-BF5B-F8F4B78F994EQ38851470-289EA267-6B2E-4378-B34C-998FB1D0A5F5Q38962768-2035687E-B2DE-4C6B-8A22-B136577C04E6Q39285509-E9976DB7-9D6C-4290-A8A0-64EF47088FBFQ39327876-FCE0DE09-EC7E-4791-B74C-0F8860EA9EB4Q41147176-7C820405-586C-40B1-8B9D-95758C92570BQ41618060-91BF6F71-FE0B-4685-BD84-C437FCF1E875Q42247989-1840E326-05BF-439E-A554-F8D74F6DE671Q42362245-63786631-9044-438D-AFFF-6BB90A6BD0CFQ47751388-07607323-F725-4E16-BC64-1151B1F72C61Q47767234-0D7DDBD8-0769-453B-B30C-7C2BD1F34820Q47959430-AEE42E1A-42FB-4F97-84FF-55ECE80A2FD0Q48275729-609B749B-46EE-449A-BA9C-DCB37566D7CFQ49478156-D5B57083-A733-4679-80F8-037B50882618Q49572104-30A76F3C-5AEF-49C8-AE18-AF5062FF88C2Q50067304-DAE2286C-754D-442B-AFFB-331844DB4206Q50070001-50508B2C-7671-44BC-84DC-5540906797D9Q50114657-768A54BC-30A0-4B8B-8022-F5366E4E404CQ51244908-C131FBF4-79CC-49C4-84C9-D942A69BBAE0Q51730813-4402AC12-1046-4A66-AAE7-B31DE5AAE91CQ52718518-67957503-1CC9-420F-A39F-67E60DFAD419Q53285289-4B75EB58-278A-4DB5-95D9-31A4DCC5C2A2Q55057811-895775B6-EEF1-488B-BBF0-EC5B68936C10Q55085404-7E91675B-28CF-4B62-8096-791B688022FFQ55314327-28561D72-F76C-47DA-B4DF-86F2E58BF314
P2860
Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Epidemiology of Atherosclerosi ...... n of Atherothrombotic Disease.
@ast
Epidemiology of Atherosclerosi ...... n of Atherothrombotic Disease.
@en
Epidemiology of Atherosclerosi ...... n of Atherothrombotic Disease.
@nl
type
label
Epidemiology of Atherosclerosi ...... n of Atherothrombotic Disease.
@ast
Epidemiology of Atherosclerosi ...... n of Atherothrombotic Disease.
@en
Epidemiology of Atherosclerosi ...... n of Atherothrombotic Disease.
@nl
prefLabel
Epidemiology of Atherosclerosi ...... n of Atherothrombotic Disease.
@ast
Epidemiology of Atherosclerosi ...... n of Atherothrombotic Disease.
@en
Epidemiology of Atherosclerosi ...... n of Atherothrombotic Disease.
@nl
P2093
P1433
P1476
Epidemiology of Atherosclerosi ...... en of Atherothrombotic Disease
@en
P2093
Jane Armitage
Paul Sherliker
Sarah Lewington
P304
P356
10.1161/CIRCRESAHA.115.307611
P577
2016-02-01T00:00:00Z